Advertisement

Tumor Biology

, Volume 34, Issue 5, pp 2943–2949 | Cite as

Expression and biological roles of SATB1 in human bladder cancer

Research Article

Abstract

Special AT-rich sequence-binding protein-1 (SATB1) has been recently reported to be overexpressed in various cancers and associate with the malignant behavior of cancer cells. However, the expression and potential roles of SATB1 in bladder cancer remains unclear. In the present study, SATB1 expression was analyzed in 85 archived bladder cancer specimens using immunohistochemistry and the correlations between SATB1 expression and clinicopathological parameters were evaluated. To further explore the biological functions of SATB1 in bladder cancer, siRNA knockdown was performed in 5637 and T24 bladder cancer cell lines. We then carried out CCK8 assay and examined cisplatin-induced apoptosis to address the roles of SATB1 in proliferation and apoptosis. We found that SATB1 was overexpressed in 33 of 85 (38.8 %) bladder cancer specimens. SATB1 overexpression associated with tumor grade (p = 0.002) and tumor stage (p = 0.027). SATB1 depletion in 5637 and T24 cells decreased cell proliferation while upregulating cisplatin-induced apoptosis. Further study demonstrated that SATB1 knockdown decreased cyclin D1 and cyclin E expression and upregulated caspase3 cleavage. In conclusion, SATB1 is overexpressed in bladder cancer and regulates malignant cell growth and apoptosis, which makes SATB1 a therapeutic target candidate for bladder cancer.

Keywords

SATB1 Bladder cancer Proliferation Cyclin D1 

Notes

Conflicts of interest

No potential conflicts of interest were disclosed.

References

  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62(1):10–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Wahafu W, He ZS, Zhang XY, Zhang CJ, Yao K, Hao H, et al. The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells. Tumour Biol. 2011;32(5):931–9. doi: 10.1007/s13277-011-0195-0. Epub 2011 Jun 22.CrossRefPubMedGoogle Scholar
  3. 3.
    Shan GY, Zhang Z, Chen QG, Yu XY, Liu GB, Kong CZ. Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma. Tumour Biol. 2012;33(3):847–55. doi: 10.1007/s13277-011-0311-1. Epub 2012 Jan 17.CrossRefPubMedGoogle Scholar
  4. 4.
    Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell. 1992;70(4):631–45.CrossRefPubMedGoogle Scholar
  5. 5.
    Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, Kohwi-Shigematsu T. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T cell development. Genes Dev. 2000;14(5):521–35.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Dickinson LA, Dickinson CD, Kohwi-Shigematsu T. An atypical homeodomain in SATB1 promotes specific recognition of the key structural element in a matrix attachment region. J Biol Chem. 1997;272(17):11463–70.CrossRefPubMedGoogle Scholar
  7. 7.
    Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T, Noguchi CT. SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood. 2005;105(8):3330–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Kumar PP, Purbey PK, Ravi DS, Mitra D, Galande S. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol Cell Biol. 2005;25(5):1620–33.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature. 2008;452(7184):187–93.CrossRefPubMedGoogle Scholar
  10. 10.
    Patani N, Jiang W, Mansel R, Newbold R, Mokbel K. The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int. 2009;9:18.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Chen H, Takahara M, Oba J, Xie L, Chiba T, Takeuchi S, et al. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci. 2011;64(1):39–44. doi: 10.1016/j.jdermsci.2011.06.007. Epub 2011 Jun 23.CrossRefPubMedGoogle Scholar
  12. 12.
    Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S, et al. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS. 2010;118(11):855–63. doi: 10.1111/j.1600-0463.2010.02673.x. Epub 2010 Sep 2.CrossRefPubMedGoogle Scholar
  13. 13.
    Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, Wang R, et al. Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis. 2012;27(2):143–50. doi: 10.1007/s00384-011-1302-9. Epub 2011 Aug 26.CrossRefPubMedGoogle Scholar
  14. 14.
    Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ, et al. Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2010;72(1):1–5. doi: 10.1159/000264777. Epub 2010 Jan 22.CrossRefPubMedGoogle Scholar
  15. 15.
    Purbey PK, Singh S, Notani D, Kumar PP, Limaye AS, Galande S. Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Mol Cell Biol. 2009;29(5):1321–37.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Pavan Kumar P, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS, et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell. 2006;22(2):231–43.CrossRefPubMedGoogle Scholar
  17. 17.
    Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu XP, et al. Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci. 2010;101(1):80–6. doi: 10.1111/j.1349-7006.2009.01372.x. Epub 2009 Sep 26.CrossRefPubMedGoogle Scholar
  18. 18.
    Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007;98(5):629–35.CrossRefPubMedGoogle Scholar
  19. 19.
    Witzel II, Koh LF, Perkins ND. Regulation of cyclin D1 gene expression. Biochem Soc Trans. 2010;38(Pt 1):217–22. doi: 10.1042/BST0380217.CrossRefPubMedGoogle Scholar
  20. 20.
    Mazumder S, DuPree EL, Almasan A. A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr Cancer Drug Targets. 2004;4(1):65–75.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene. 2005;24(17):2776–86.CrossRefPubMedGoogle Scholar
  22. 22.
    D’Amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 2010;17(7):1104–14. doi: 10.1038/cdd.2009.180. Epub 2009 Dec 4.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of UrologyShengJing Hospital of China Medical UniversityShenyangChina
  2. 2.Department of PathologyFengtian Hospital Affiliated to Shenyang Medical CollegeShenyangChina

Personalised recommendations